Carotid Artery Plaque Recruiting Phase 2 Trials for 1,2-Distearoyllecithin (DB14099)

IndicationStatusPhase
DBCOND0033064 (Carotid Artery Plaque)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03335033New Technologies to Determine Carotid Plaque Vulnerability in Patients With Significant Carotid PlaquesBasic Science